Table 1.
Total antioxidant status and wall thickness in the study groups.
| Control (n = 8) | Vitamin C (n = 8) | Melatonin (n = 8) | p | |
|---|---|---|---|---|
| TAS before the treatment (mmoL Trolox Eq/L)a | 2.97 ± 0.86 | 2.51 ± 0.39 | 3.20 ± 0.91 | 0.199 |
| TAS after the treatment (mmoL Trolox Eq/L)a | 2.51 ± 0.64 | 5.68 ± 0.28 | 5.46 ± 0.23 | <0.001c |
| Minimum wall thicknessb | 2.35 (1.25–4.5) | 2.0 (1.0–6.9) | 2.0 (1.25–3.6) | 0.946 |
| Maximum wall thicknessa | 38 ± 27 | 33 ± 26 | 32 ± 17 | 0.847 |
TAS, total antioxidant status.
a
Values are presented as mean ± standard deviation.
b
Values are presented as median and interquartile range (Q1–Q3).
c
There were statistically significant difference between control with melatonin groups (p < 0.001) and control with vitamin C groups (p < 0.001) but vitamin C with melatonin groups was similar.